Cite

    Zile, M. R., Abraham, W. T., Weaver, F. A., Butter, C., Ducharme, A., Halbach, M., Klug, D., Lovett, E. G., Müller‐Ehmsen, J., Schafer, J. E., Senni, M., Swarup, V., Wachter, R., & Little, W. C. (2015). baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy. European journal of heart failure, 17, 1066–1074. http://access.bl.uk/ark:/81055/vdc_100027430862.0x00005d